Hospital
Gila River Health Care Corporation
Gila River Health Care Corporation was paid $4.77M by Medicaid between Jan 2018 and Nov 2024, across 104 billing codes. Its largest line is 99211, Office or other outpatient visit for the evaluation and management of an established patient, minimal severity — 74% of everything it billed.
33Billing provider infoGILA RIVER HEALTH CARE CORPORATION
SACATON, AZ 85147
SACATON, AZ 85147
33aNPI1225023179assigned 09/16/2005
33bProvider typeCritical Access Hospital
28Total paid$4.77M
24GClaims109,754
24DCodes billed104
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Arizona
Rank by total paid#9 of 15
Median peer was paid$6.92M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,380 | $726K | |
| 2019 | 18,336 | $914K | |
| 2020 | 17,296 | $1.06M | |
| 2021 | 20,208 | $1.15M | |
| 2022 | 14,355 | $389K | |
| 2023 | 13,477 | $310K | |
| 2024incomplete | 8,702 | $213K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 74% | 47,056 | 23,020 | $3.54M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.1% | 6,036 | 2,428 | $148K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.3% | 7,488 | 6,305 | $110K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.2% | 1,191 | 1,179 | $103K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.5% | 3,289 | 3,129 | $73K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.5% | 194 | 189 | $71K |
| 71046 | Radiologic examination, chest; 2 views | 1.4% | 7,042 | 7,002 | $65K |
| 76801 | 1.3% | 1,227 | 1,143 | $60K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.2% | 1,725 | 1,715 | $57K |
| H0031 | Mental health assessment, by non-physician | <1% | 202 | 195 | $47K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 600 | 569 | $38K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,537 | 4,451 | $37K |
92 more codes
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 797 | $33K |
| 97760 | <1% | 1,239 | $30K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 728 | $27K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 680 | $25K |
| 73630 | <1% | 3,190 | $24K | |
| 99307 | <1% | 1,791 | $23K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 775 | $21K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 536 | $20K |
| 76830 | Ultrasound, transvaginal | <1% | 558 | $19K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 448 | $17K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 450 | $17K |
| 99283 | Emergency room visit (moderate) | <1% | 666 | $16K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 315 | $15K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 30 | $14K |
| 97162 | <1% | 308 | $14K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,472 | $13K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 145 | $11K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 213 | $7K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 92 | $7K |
| 97161 | <1% | 125 | $7K | |
| 99284 | Emergency room visit (serious) | <1% | 71 | $6K |
| 73610 | <1% | 671 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 470 | $5K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 323 | $4K |
| 73564 | <1% | 292 | $3K | |
| 99442 | <1% | 274 | $3K | |
| 99443 | <1% | 113 | $2K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 37 | $2K |
| 73130 | <1% | 301 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 61 | $2K |
| 99310 | Prolong nursin fac eval 15m | <1% | 43 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 577 | $2K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 96 | $1K |
| 73562 | <1% | 153 | $1K | |
| T1016 | Case management, each 15 minutes | <1% | 26 | $1K |
| 92250 | <1% | 250 | $1K | |
| 73030 | <1% | 142 | $1K | |
| 93971 | <1% | 63 | $1K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 43 | $1K |
| 99441 | <1% | 173 | $1K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 58 | $895.79 |
| 73110 | <1% | 79 | $623.76 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 174 | $581.53 |
| 80053 | Comprehensive metabolic panel | <1% | 1,172 | $495.50 |
| 82607 | <1% | 395 | $426.17 | |
| 90686 | <1% | 650 | $421.42 | |
| 72110 | <1% | 32 | $388.58 | |
| 76536 | <1% | 13 | $348.10 | |
| 93925 | <1% | 12 | $340.88 | |
| 20610 | <1% | 30 | $311.47 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 48 | $204.66 |
| 90688 | <1% | 147 | $152.50 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 109 | $135.20 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,111 | $115.85 |
| 80061 | Lipid panel | <1% | 699 | $114.32 |
| 90750 | <1% | 92 | $112.23 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,194 | $81.28 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 91 | $80.25 |
| 97116 | <1% | 22 | $74.95 | |
| 92134 | <1% | 13 | $61.92 | |
| 81001 | <1% | 673 | $51.42 | |
| 80050 | General health panel | <1% | 256 | $42.00 |
| 81025 | <1% | 407 | $34.35 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 66 | $26.54 |
| 82746 | <1% | 129 | $9.24 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 136 | $7.15 |
| G0008 | Administration of influenza virus vaccine | 0% | 572 | $0.00 |
| 82043 | 0% | 116 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 166 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 172 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 98 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 49 | $0.00 |
| 90694 | 0% | 135 | $0.00 | |
| 90656 | 0% | 35 | $0.00 | |
| 86592 | 0% | 65 | $0.00 | |
| 0134A | 0% | 45 | $0.00 | |
| 90480 | 0% | 68 | $0.00 | |
| 87430 | 0% | 25 | $0.00 | |
| 86803 | 0% | 12 | $0.00 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 12 | $0.00 |
| 0124A | 0% | 31 | $0.00 | |
| 82570 | 0% | 145 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 206 | $0.00 |
| 91322 | 0% | 44 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 169 | $0.00 |
| 90662 | 0% | 131 | $0.00 | |
| 90687 | 0% | 171 | $0.00 | |
| 91320 | 0% | 18 | $0.00 | |
| 80074 | 0% | 42 | $0.00 | |
| 84439 | 0% | 26 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 44 | $0.00 |
| 90714 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSANTIAGO, ANTHONY (CEO)
| Provider | Location | Paid |
|---|---|---|
| Gila River Health Care | Laveen, AZ | $16.06M |
| Gila River Health Care Corporation | Chandler, AZ | $2.50M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.